$20 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 159 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NSTDWS | Exit | NORTHERN STAR INVEST CORP IV*w exp 02/25/202 | $0 | – | -16,666 | -100.0% | 0.00% | – |
| Exit | BLUE WHALE ACQUISITION CORP*w exp 07/30/202 | $0 | – | -143,750 | -100.0% | 0.00% | – | |
| Exit | UTA ACQUISITION CORPORATION*w exp 10/30/202 | $0 | – | -175,000 | -100.0% | 0.00% | – | |
| PMGMW | Exit | PRIVETERRA ACQUISITION CORP*w exp 02/28/202 | $0 | – | -49,995 | -100.0% | 0.00% | – |
| Exit | CORSAIR PARTNERING CORP*w exp 07/06/202 | $0 | – | -233,330 | -100.0% | 0.00% | – | |
| FMIVW | Exit | FORUM MERGER IV CORP*w exp 03/15/202 | $0 | – | -250,000 | -100.0% | 0.00% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -5,800 | -100.0% | -0.00% | – |
| CLVR | Exit | CLEVER LEAVES HOLDINGS INC | $0 | – | -1,629,363 | -100.0% | -0.00% | – |
| Exit | BETTER THERAPEUTICS INC | $0 | – | -330,619 | -100.0% | -0.00% | – | |
| AVRO | Exit | AVROBIO INC | $0 | – | -899,700 | -100.0% | -0.00% | – |
| ICE | Exit | INTERCONTINENTAL EXCHANGE IN | $0 | – | -12,786 | -100.0% | -0.01% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -74,000 | -100.0% | -0.01% | – |
| Exit | ATENTO S A | $0 | – | -2,230,357 | -100.0% | -0.01% | – | |
| Exit | ALVOTECHordinary shares | $0 | – | -437,110 | -100.0% | -0.02% | – | |
| Exit | UTA ACQUISITION CORPORATION | $0 | – | -344,100 | -100.0% | -0.02% | – | |
| Exit | CARTICA ACQUISITION CORP | $0 | – | -350,000 | -100.0% | -0.02% | – | |
| ISEE | Exit | IVERIC BIO INCput | $0 | – | -100,000 | -100.0% | -0.02% | – |
| FSRX | Exit | FINSERV ACQUISITION CORP II | $0 | – | -400,000 | -100.0% | -0.02% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -116,000 | -100.0% | -0.02% | – |
| Exit | BLUE WHALE ACQUISITION CORP | $0 | – | -575,000 | -100.0% | -0.03% | – | |
| Exit | CORSAIR PARTNERING CORP | $0 | – | -700,000 | -100.0% | -0.04% | – | |
| Exit | ARYA SCIENCES ACQUISITN CORP V | $0 | – | -745,000 | -100.0% | -0.04% | – | |
| Exit | KENSINGTON CAPITAL ACQUISITI V | $0 | – | -775,200 | -100.0% | -0.04% | – | |
| BRKR | Exit | BRUKER CORP | $0 | – | -150,476 | -100.0% | -0.06% | – |
| LSI | Exit | LIFE STORAGE INC | $0 | – | -89,794 | -100.0% | -0.06% | – |
| Exit | SPOTIFY USA INCnote 3/1 | $0 | – | -16,500,000 | -100.0% | -0.07% | – | |
| AEL | Exit | AMERICAN EQTY INVT LIFE HLD | $0 | – | -383,000 | -100.0% | -0.10% | – |
| Exit | DRAFTKINGS INC NEWnote 3/1 | $0 | – | -30,000,000 | -100.0% | -0.12% | – | |
| AMAM | Exit | AMBRX BIOPHARMA INCsponsored ads | $0 | – | -2,269,000 | -100.0% | -0.19% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -193,267 | -100.0% | -0.22% | – |
| TSEM | Exit | TOWER SEMICONDUCTOR LTD | $0 | – | -1,160,000 | -100.0% | -0.23% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -451,700 | -100.0% | -0.24% | – |
| AJRD | Exit | AEROJET ROCKETDYNE HLDGS INC | $0 | – | -959,378 | -100.0% | -0.27% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -602,000 | -100.0% | -0.29% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -1,523,000 | -100.0% | -0.30% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -161,000 | -100.0% | -0.33% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -2,442,299 | -100.0% | -0.50% | – |
| Exit | SEA LTDnote 0.250% 9/1 | $0 | – | -150,000,000 | -100.0% | -0.63% | – | |
| Exit | HELLO GROUP INCnote 1.250% 7/0 | $0 | – | -123,449,000 | -100.0% | -0.64% | – | |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -3,075,000 | -100.0% | -0.67% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -604,098 | -100.0% | -0.89% | – |
| EFX | Exit | EQUIFAX INC | $0 | – | -1,058,697 | -100.0% | -1.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.